by admin | Dec 13, 2016 | Stem Cell News
New York, Dec 13 (IANS) Researchers have identified that bone marrow-derived cells are the source of suPAR — a protein recently identified as both a reliable marker for chronic kidney disease and a pathogen of the often deadly condition. The place of origin of...
by admin | Dec 12, 2016 | Stem Cell News
At first, doctors thought it was carpal tunnel syndrome. The diagnosis made sense to Shannon Abert, a high school algebra teacher whose hands couldn’t scratch out equations on the chalkboard like they used to. But treatments didn’t help and, soon enough,...
by admin | Dec 12, 2016 | Stem Cell News
Tip : Use comma (,) to separate multiple quotes. Learn more… Mon, Dec 12, 2016, 17:05 GMT – UK Markets closed Defymed Enters Partnership with Semma Therapeutics Press Release : Defymed – 35 minutes ago Print STRASBOURG, France–(BUSINESSWIRE)–...
by admin | Dec 12, 2016 | Stem Cell News
TORONTO (Reuters) – German chemicals and healthcare group Bayer said it had set up a joint venture with U.S. life sciences venture capital firm Versant Ventures to invest $225 million in stem cell therapy technology. The companies said the financing, one of the...
by admin | Dec 12, 2016 | Stem Cell News
Share ALAMEDA, Calif.–(BUSINESS WIRE)– BioTime, Inc. (NYSE MKT: BTX), a clinical-stage biotechnology company developing and commercializing products addressing degenerative diseases, today announced that Co-Chief Executive Officer Michael D. West, Ph.D.,...
